FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Novartis | e.coli

New Novartis vaccine guards mice against E. coli

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools
  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

After mapping the gene for the E. coli bacterium, researchers for Novartis believe that they have found the key elements needed to create a vaccine that can protect people from all the bacterial infections that E. coli can cause.

The mapping program successfully guided scientists to nine antigens that protected mice from E. coli. Certain strains of the bacteria in meat and produce can cause a violent physical reaction in people ranging from blood poisoning to neonatal meningitis.

"We know that we have the potential there, and this could mean that once you get vaccinated you could even be covered against all the different diseases that E. coli can cause," Novartis researcher Mariagrazia Pizza told Reuters. "The development of such a vaccine will be very challenging for the company, but if we were successful at the end, obviously it would be a big thing."

- here's the story from Red Orbit
-
see the Reuters article

Related Articles:
Researcher develops new vaccine for E. Coli killer
Novartis vax division booms as demand spikes
Gene-mapping unlocks new generation of vaccines


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Novartis   e.coli